Kathleen M. Nicholls is a nephrologist based on Grattan St in Parkville, VIC. She looks after people with kidney and fluid balance issues, as well as some rare inherited conditions that can affect the kidneys and other organs too.
In day to day practice, she commonly helps with chronic kidney disease, glomerulonephritis, and lupus nephritis. These are often ongoing problems, so care can be about long-term planning, regular checks, and making sure treatment fits real life at home.
Kathleen also works with patients who have rare conditions where kidney symptoms can be part of the bigger picture. This can include Fabry disease, Gaucher disease, the mucopolysaccharidoses such as Hurler (MPS I) and Hunter (MPS II), and Pompe disease. Sometimes these conditions can show up in more than one way, like changes in the heart, blood vessels, or general health, so care needs to be coordinated and steady.
Another area she sees is diabetes insipidus. That might be nephrogenic diabetes insipidus, where the body struggles to respond to signals that control urine and thirst. People can feel very thirsty, pass large amounts of urine, and end up feeling wiped out. Getting the balance right can take time, and it often involves close follow-up.
Kathleen’s work also includes conditions linked with blood vessel and bleeding patterns, such as hereditary haemorrhagic telangiectasia, and issues like telangiectasia. At times, she may help manage kidney-related effects that come with these conditions, alongside other specialists.
Because some diagnoses are complex, she focuses on clear explanations and practical next steps. Patients usually need a plan that considers both kidneys and the rest of the body, especially when there are rare disorders involved.
Her education includes specialist training in nephrology, with the kind of grounding needed to manage kidney disease and related conditions safely and thoughtfully. Over time, her clinical work sits alongside the broader medical research world for rare diseases, and this can include links to clinical trials when they’re available and suitable.